date:Oct 30, 2012
e and enforce compliance with federal law, FSMA imposes significant implementation obligations on the agency. Whether due to challenging legal or scientific questions, resource limitations, election-year politics, or some combination of all three, FDA has failed to meet some of these obligations within the timeframes prescribed by FSMA.
For example, months have passed since the deadline for final regulations implementing what is perhaps FSMAs signature provision, which requires each facility to